Cwestiwn ysgrifenedig WQ97451
- Gofynnwyd gan
- Samuel KurtzCeidwadwyr
- I'w ateb gan
- Cabinet Secretary for Health and Social Care
- Cyflwynwyd
- Dyddiad ateb
- Atebwyd
- Amser i'w ateb
- 9 diwrnod
Cwestiwn
Mae'r cwestiwn a'r ateb yn Saesneg gan nad oes fersiwn Gymraeg ar gael.
Will the Cabinet Secretary confirm whether drugs such as Mounjaro (tirzepatide), or Wegovy (semaglutide), can be prescribed for weight loss on the Welsh NHS?
Ateb
Atebwyd gan Cabinet Secretary for Health and Social Care
Weight loss drugs are available for prescription, across health boards, in Wales through specialist services as set out within the All-Wales Weight Management Pathway.
The All Wales Weight Management Pathway (Adult weight management pathway 2021 | GOV.WALES) sets out our approach to the development of weight management services for patients in Wales, from early intervention to specialist support, and is consistent with National Institute for Health and Care Excellence (NICE) guidance. An addendum to the guidance sets out that weight management medication can be prescribed by a specialist service, where clinically indicated and in combination with a behavioural (lifestyle) intervention that includes a reduced-calorie diet and increased physical activity.
Further information on tirzepatide (Mounjaro) for weight management, published by Welsh Health Circular in May, can be found here: Tirzepatide (Mounjaro®) for the management of obesity and overweight (WHC/2025/018) [HTML] | GOV.WALES